- ￥2588 - 9188
- abinScience
- France
- VK565020
- 2025年07月14日
- Neutralization
- Human
- SARS-CoV-2
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG1, kappa
- 形态：
Liquid
- 保存条件：
-20°C
- 克隆性：
单克隆
- 适应物种：
SARS-CoV-2
- 保质期：
12 months
- 级别：
一抗
- 供应商：
武汉益普生物科技有限公司
- 宿主：
Human
- 应用范围：
Neutralization
- 浓度：
1 mg/ml
- 抗体英文名：
InVivoMAb Anti-pan SARS-CoV-2 RBD Antibody (1H1)
- 规格：
100μg/1mg
| 规格： | 100μg | 产品价格： | ￥2588.0 |
|---|---|---|---|
| 规格： | 1mg | 产品价格： | ￥9188.0 |
| Product name | InVivoMAb Anti-pan SARS-CoV-2 RBD Antibody (1H1) |
| Catalog No. | VK565020 |
| Target | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, RBD, Spike protein S1, S, Receptor-Binding Domain, SARS-CoV-2 |
| Clonality | Monoclonal |
| Host species | Human |
| Species reactivity | SARS-CoV-2 |
| Applications | Neutralization |
| Isotype | IgG1, kappa |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Concentration | 1 mg/ml |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Preprint at bioRxiv 11: Lynch, KL et al. (2020) Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity. Preprint
于较低亲和力的相互作用，不能使用经典LowCross Buffer®设置的截止值进行。对于这些分析，LowCross Buffer®MILD可能是有益的。尽管如此，对于大多数应用，LowCross Buffer®的经典配方可完美平衡干扰抑制和真正信号保护。 Figure 3: Improving an RBD-based SARS-CoV-2 antibody ELISA using LowCross-Buffer. Comparison of negative samples (# 1-20
技术资料暂无技术资料 索取技术资料
